Literature DB >> 7769665

Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines.

J Schaack1, X Guo, W Y Ho, M Karlok, C Chen, D Ornelles.   

Abstract

HeLa and 293 cell lines that express biologically active adenovirus type 5 precursor terminal protein (pTP) have been made. The amount of pTP synthesized in these cell lines ranges from barely detectable to greater than that observed in cells infected with the wild-type virus. The pTP-expressing cell lines permit the growth of a temperature-sensitive terminal protein mutant virus sub100r at the nonpermissive temperature. A higher percentage of the stably transfected 293 cell lines expressed terminal protein, and generally at considerably higher levels, than did the HeLa cell lines. While 293 cells appeared to tolerate pTP better than did HeLa cells, high-level pTP expression in 293 cells led to a significantly reduced growth rate. The 293-pTP cell lines produce infectious virus after transfection with purified viral DNA and form plaques when overlaid with Noble agar after infection at low multiplicity. These cell lines offer promise for the production of adenoviruses lacking pTP expression and therefore completely defective for replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769665      PMCID: PMC189142          DOI: 10.1128/JVI.69.7.4079-4085.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  Inducible overproduction of the mouse c-myc protein in mammalian cells.

Authors:  F M Wurm; K A Gwinn; R E Kingston
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Heat shock proteins within the mammalian cell cycle: relationship to thermal sensitivity, thermal tolerance, and cell cycle progression.

Authors:  G Rice; A Laszlo; G Li; J Gray; W Dewey
Journal:  J Cell Physiol       Date:  1986-02       Impact factor: 6.384

4.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

Review 5.  The replication of adenovirus DNA with purified proteins.

Authors:  B W Stillman
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

6.  Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells.

Authors:  T Shenk; N Jones; W Colby; D Fowlkes
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

7.  Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell.

Authors:  D F Klessig; D E Brough; V Cleghon
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

8.  Cell cycle control of the human HSP70 gene: implications for the role of a cellular E1A-like function.

Authors:  H T Kao; O Capasso; N Heintz; J R Nevins
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

9.  Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase.

Authors:  J Schaack; S Langer; X Guo
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  Easy identification of cDNA clones.

Authors:  U Rüther; B Müller-Hill
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  18 in total

1.  Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Authors:  D Hartigan-O'Connor; A Amalfitano; J S Chamberlain
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency.

Authors:  B T Tan; L Wu; A J Berk
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Transcriptional response of the murine mammary gland to acute progesterone exposure.

Authors:  Rodrigo Fernandez-Valdivia; Atish Mukherjee; Chad J Creighton; Adam C Buser; Francesco J DeMayo; Dean P Edwards; John P Lydon
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

4.  Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.

Authors:  A Amalfitano; C R Begy; J S Chamberlain
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

Authors:  R J Parks; L Chen; M Anton; U Sankar; M A Rudnicki; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.

Authors:  R J Parks; F L Graham
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells.

Authors:  A Lieber; M A Kay; Z Y Li
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene.

Authors:  J Schaack; X Guo; S J Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

9.  A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears.

Authors:  J W Moorhead; G H Clayton; R L Smith; J Schaack
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.

Authors:  P Yeh; J F Dedieu; C Orsini; E Vigne; P Denefle; M Perricaudet
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.